HBIO News and Press, Harvard Bioscience Inc.

HOLLISTON, Mass., June 06, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be presenting to investors at the 14 th Annual East Coast IDEAS Conference at the ...

HOLLISTON, Mass., May 23, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be presenting to investors at the Jefferies Global Healthcare Conference at the Marriot...

HOLLISTON, Mass., May 16, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be participating in the Benchmark Healthcare House Call Virtual Conference on May 22 ...

2024-05-12 12:40:00 ET Summary Riverwater Partners is a Milwaukee-based investment advisory firm dedicated to responsible investing. Our mission is to make the world a better place by growing wealth through sustainable investing. The Micro Opportunities Strategy underperformed its...

2024-05-07 12:52:06 ET Harvard Bioscience, Inc. (HBIO) Q1 2024 Earnings Conference Call May 07, 2024, 08:00 AM ET Company Participants Dave Sirois - Director, SEC Reporting Jim Green - Chairman, President and CEO Jennifer Cote - CFO Conference Call Particip...

2024-05-07 07:12:52 ET More on Harvard Bioscience Harvard Bioscience, Inc. (HBIO) Q4 2023 Earnings Call Transcript Harvard Bioscience, Inc. 2023 Q4 - Results - Earnings Call Presentation Harvard Bioscience Q1 2024 Earnings Preview Seeking Alpha’s Quant...

Aterian Inc. (ATER) is expected to report for Q1 2024 Dorman Products Inc. (DORM) is expected to report $0.82 for Q1 2024 Hillman Solutions Corp. (HLMN) is expected to report $0.08 for Q1 2024 Wake Forest Bancshares, Inc. (WAKE) is expected to report for quarter end 2024-03-31 Inn...

HOLLISTON, Mass., May 07, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the first quarter ended March 31, 2024. Jim Green, Chairman and CEO, said, “As expected, our first quarter revenues reflect o...

2024-05-06 11:08:27 ET Major earnings expected before the bell on Tuesday include: BP p.l.c. ( BP ) Datadog ( DDOG ) The Walt Disney ( DIS ) Duke Energy ( DUK ) Nikola ( NKLA ) Read the full article on Seeking Alpha For further details...

2024-05-06 10:56:49 ET More on Harvard Bioscience Harvard Bioscience, Inc. (HBIO) Q4 2023 Earnings Call Transcript Harvard Bioscience, Inc. 2023 Q4 - Results - Earnings Call Presentation Seeking Alpha’s Quant Rating on Harvard Bioscience Historical ear...